EP Patent

EP2666463A1 — Stabilized liquid composition comprising pemetrexed

Assigned to Synthon BV · Expires 2013-11-27 · 12y expired

What this patent protects

The present invention relates to a stabilized liquid pharmaceutical composition comprising pemetrexed or a pharmaceutically acceptable salt thereof, monothioglycerol, a] at least one non-ionogenic water soluble polymer and/or b] an edetate.

USPTO Abstract

The present invention relates to a stabilized liquid pharmaceutical composition comprising pemetrexed or a pharmaceutically acceptable salt thereof, monothioglycerol, a] at least one non-ionogenic water soluble polymer and/or b] an edetate.

Drugs covered by this patent

Patent Metadata

Patent number
EP2666463A1
Jurisdiction
EP
Classification
—
Expires
2013-11-27
Drug substance claim
No
Drug product claim
No
Assignee
Synthon BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.